Updated Jan. 8, 2019 Medical device company stocks are not looking as rosy as they did two months ago, but the medtech industry still appears to be resisting the overall downward trend in stock markets, according to a Medical Design & Outsourcinganalysis. More than half of the roughly 100 largest medical device companies in the world […]
AtriCure falls despite solid Q4, 2018 prelims | Wall Street Beat
AtriCure (NSDQ:ATRC) shares took a fall today despite preliminary results for the fourth quarter and 2018 that topped estimates. The Mason, Ohio-based cardiac implant maker said it expects to post Q4 sales of $52.9 million and 2018 sales of $201.6 million, beating the consensus estimatyes on Wall Street for both periods. “We are pleased with our […]
AtriCure posts mixed bag Q3
AtriCure (NSDQ:ATRC) today posted third quarter earnings that beat Wall Street expectations for sales, but missed on loss-per-share consensus. The Mason, Ohio-based company posted losses of $7.2 million, or 22¢ per share, on sales of $49.9 million for the three months ended September 30, seeing profits drop 0.2% while sales grew 18.5% compared with the same […]
These 10 medtech companies care a lot about research
These 10 medical device companies spent the largest portion of their budgets on research and development. Here’s a look at what they produced. Each year, Medical Design & Outsourcing compiles a list of the top 100 medical device companies across the globe and ranks the companies based on annual revenue for the most recent fiscal […]
AtriCure prices $72m offering
AtriCure (NSDQ:ATRC) yesterday priced an upcoming offering, looking to raise approximately $72 million. The Mason, Ohio-based company said it will look to offer 2.5 million shares of its common stock at a price of $30.75 per share, bringing in a total of $72 million in net proceeds after discounts and expenses. The offering comes with an additional […]
AtriCure posts Street-topping Q3 prelims
AtriCure (NSDQ:ATRC) late yesterday released preliminary earnings for the third quarter that beat consensus on Wall Street. The Mason, Ohio-based company said it expects to post sales of $49.9 million, which reflects growth of approximately 18.5% over its third quarter from the previous fiscal year. US-based revenue is expected to be $39.8 million, while international sales […]
AtriCure posts Street-beating Q2, raises sales outlook
AtriCure (NSDQ:ATRC) today posted second quarter earnings that beat expectations on Wall Street and lifted its sales guidance for the remaining year. The Mason, Ohio-based company posted losses of $338,000, or 1¢ per share, on sales of $51.8 million for the three months ended June 30, seeing losses shrink 95.1% while sales grew 14.5% compared with […]
AtriCure inks multi-year Chinese distro deal with Baheal Pharma
AtriCure (NSDQ:ATRC) said today it inked a multi-year partnership deal with China’s Baheal Pharmaceutical Group to distribute AtriCure’s surgical ablation devices. Through the deal, Baheal will become Mason, Ohio-based AtriCure’s exclusive distributor in the region, replacing the company’s previous distribution partner. “At Baheal, we’re continuously looking for ways to grow and expand our business. We believe […]
AtriCure jumps on Q1 profit increase
Shares in AtriCure (NSDQ:ATRC) got a boost today after the cardiovascular company’s first-quarter numbers showed a nearly 14% top-line gain and shaved a penny off its quarterly earnings loss. Mason, Ohio-based AtriCure posted losses of -$10.1 million, or -31¢ per share, on sales of $47.0 million for the three months ended March 31, cutting its losses […]
AtriCure beats the Street during Q4, analysts predict ‘growth acceleration’
AtriCure (Nasdaq: ATRC) — an innovator in treatments for atrial fibrillation and left atrial appendage management — is enjoying a rise in its stock value today after releasing results that beat the Street. Mason, Ohio–based AtriCure’s stock was up 67 cents per share, or 3.7%, closing at $18.99. The company reported yesterday evening that it revenue for […]
ActriCure launches AtriClip Flex V
AtriCure (NSDQ:ATRC) said yesterday that it won 510(k) clearance from the FDA for its AtriClip Flex V left atrial appendage closure device, touting it as the first AtriClip device with a trigger release for deployment. “The AtriClip Flex V is an exciting new product that we are pleased to be releasing to our U.S. customers,” president […]
- 1
- 2
- 3
- …
- 9
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
YouTube